Publications by authors named "Orhan Sezer"

Claim this Profile
E
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
Laura Rosiñol, Meral Beksac, Elena Zamagni, Niels W C J Van de Donk, Kenneth C Anderson, Orhan Sezer

Br J Haematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
Philippe Moreau, Shaji K Kumar, Jesús San Miguel, Faith Davies, Elena Zamagni, Orhan Sezer

Lancet Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.
Stefan Knop, Monika Engelhardt, Peter Liebisch, Christoph Meisner, Ernst Holler, Orhan Sezer

Leukemia· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Orhan Sezer, Meral Beksac, Roman Hajek, Gülsan Sucak, Seckin Cagirgan

Br J Haematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
Christian Straka, Peter Liebisch, Hans Salwender, Burkhard Hennemann, Bernd Metzner, Orhan Sezer

Haematologica· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
Sergio Giralt, Laurent Garderet, Brian Durie, Gordon Cook, Gosta Gahrton, Orhan Sezer

Biol Blood Marrow Transplant· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Myeloma Network guidelines for the management of multiple myeloma-related complications.
Evangelos Terpos, Martina Kleber, Monika Engelhardt, Sonja Zweegman, Francesca Gay, Orhan Sezer

Haematologica· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma.
Christian Straka, Hans Salwender, Brigitte Schnabel, Michael Sandherr, Hannes Wandt, Orhan Sezer

Leuk Lymphoma· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.
Meletios A Dimopoulos, Jens Hillengass, Saad Usmani, Elena Zamagni, Suzanne Lentzsch, Orhan Sezer

J Clin Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
S Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, Orhan Sezer

Lancet Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.
Niels W C J van de Donk, Antonio Palumbo, Hans Erik Johnsen, Monika Engelhardt, Francesca Gay, Orhan Sezer

Haematologica· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma.
Jesús F San-Miguel, Paul G Richardson, Andreas Günther, Orhan Sezer, David Siegel

J Clin Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.
Evangelos Terpos, Gareth Morgan, Meletios A Dimopoulos, Matthew T Drake, Suzanne Lentzsch, Orhan Sezer

J Clin Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling.
Martin F Kaiser, Ulrike Heider, Maren Mieth, Chuanbing Zang, Ivana von Metzler, Orhan Sezer

Eur J Haematol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.
Sebastian Kobold, Tim Luetkens, Britta Marlen Bartels, Yanran Cao, York Hildebrandt, Orhan Sezer

Clin Dev Immunol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-cultural differences in information disclosure evaluated through the EORTC questionnaires.
Juan Ignacio Arraras, Eva Greimel, Wei-Chu Chie, Orhan Sezer, Mia Bergenmar

Psychooncology· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of interleukin 16 in multiple myeloma.
Djordje Atanackovic, York Hildebrandt, Julia Templin, Yanran Cao, Christiane Keller, Orhan Sezer

J Natl Cancer Inst· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases.
Britta Lamottke, Martin Kaiser, Maren Mieth, Ulrike Heider, Zhenhai Gao, Orhan Sezer

Eur J Haematol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation.
Sebastian Kobold, Sinje Tams, Tim Luetkens, Yanran Cao, Orhan Sezer

Clin Dev Immunol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to manage neutropenia in multiple myeloma.
Antonio Palumbo, Jon Bladé, Mario Boccadoro, Carmela Palladino, Faith Davies, Orhan Sezer

Clin Lymphoma Myeloma Leuk· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).
Antonio Palumbo, Sara Bringhen, Heinz Ludwig, Meletios A Dimopoulos, Joan Bladé, Orhan Sezer

Blood· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
Michele Cavo, S Vincent Rajkumar, Antonio Palumbo, Philippe Moreau, Robert Orlowski, Orhan Sezer

Blood· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Information disclosure to cancer patients: EORTC QLQ-INFO25 questionnaire.
Juan Ignacio Arraras, Eva Greimel, Wei-Chu Chie, Orhan Sezer, Mia Bergenmar

Expert Rev Pharmacoecon Outcomes Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
S Vincent Rajkumar, Jean-Luc Harousseau, Brian Durie, Kenneth C Anderson, Meletios Dimopoulos, Orhan Sezer

Blood· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.
Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, John Shaughnessy, Antonio Palumbo, Orhan Sezer

Blood· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis